Comparison of clinical outcomes in patients with mixed angina and pure vasospastic angina

被引:0
|
作者
Song, Zhao Yan [1 ]
Kim, Moo Hyun [1 ]
Lee, Kwang Min [1 ]
机构
[1] Dong A Univ Hosp, Dept Cardiol, 26 Daesingongwon Ro, Busan, South Korea
基金
新加坡国家研究基金会;
关键词
clinical outcomes; coronary artery spasm; vasospastic angina; CORONARY-ARTERY SPASM; LONG-TERM PROGNOSIS; VARIANT ANGINA; RISK-FACTORS; MYOCARDIAL-INFARCTION; ORGANIC STENOSIS; DIAGNOSIS; PECTORIS; DEATH;
D O I
10.1097/MCA.0000000000001330
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective This study investigated differences in clinical outcomes between mixed angina (MA) and pure vasospastic angina (PVA). Methods A total of 524 vasospastic angina patients who did or did not have >50% coronary artery stenosis from January 2005 to January 2021 were divided into two groups (Group 1: PVA, N = 399; Group 2: MA, N = 125) and then three groups [Group 1: PVA, N = 399; Group 2: MA without percutaneous coronary intervention (PCI), N = 67; Group 3: MA with PCI, N = 58] for assessment. We recorded the incidence of major adverse cardiac and cerebrovascular events (MACCE: the composite of death, myocardial infarction, nonfatal stroke or rehospitalization) during 3-year clinical follow-up. Results Compared to the PVA group, there were significant differences in MACCE (20.8% vs. 11.8%, P = 0.011) and rehospitalization (20.0% vs. 9.8%, P = 0.002) in the MA group. Kaplan-Meier analysis showed that patients in the MA with PCI group had the highest cumulative incidence rate of MACCE during the 3-year follow-up (log-rank P < 0.001). Conclusion Compared with the PVA patients, MA patients had significantly worse clinical outcomes during long-term follow-up.
引用
收藏
页码:270 / 276
页数:7
相关论文
共 50 条
  • [31] VASOSPASTIC ANGINA WITH HYPERTHYROIDISM
    PAPAZOGLOU, N
    KELERMENOS, N
    ANDRIOPOULOS, J
    PRIONAS, D
    HEART & LUNG, 1987, 16 (04): : 437 - 438
  • [32] THE SYMPTOMATOLOGY OF VASOSPASTIC ANGINA
    TANAKA, N
    HIRAMORI, K
    HAZE, K
    HONDA, T
    NISHIYAMA, S
    KANNO, K
    OGAWA, H
    TANAKA, E
    GOTO, Y
    SAITO, M
    SUMIYOSHI, T
    IKEDA, M
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1982, 46 (08): : 759 - 759
  • [33] Intractable vasospastic angina
    Kurata, C
    Shimane, A
    HEART, 1997, 78 (01) : 93 - 94
  • [34] Prognostic effects of benidipine in patients with vasospastic angina: Comparison with diltiazem and amlodipine
    Fukumoto, Yoshihiro
    Yasuda, Satoshi
    Ito, Akira
    Shimokawa, Hiroaki
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2008, 51 (03) : 253 - 257
  • [35] Pharmacotherapy of Vasospastic Angina
    Harris, Justin R.
    Hale, Genevieve M.
    Dasari, Tarun W.
    Schwier, Nicholas C.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 21 (05) : 439 - 451
  • [36] Management of vasospastic angina
    Beltrame, John F.
    HEART, 2023, 109 (01) : 70 - 77
  • [38] CLINICAL-SIGNIFICANCE OF TREADMILL EXERCISE TESTING IN PATIENTS WITH VASOSPASTIC ANGINA
    MASUDA, T
    YAMAKADO, T
    FUKUI, A
    NISIMURA, Y
    HIGASI, Y
    KONDO, S
    NAKANO, T
    TAKEZAWA, H
    JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION, 1986, 50 (08): : 767 - 767
  • [39] Hyperthyroidism Is Associated with the Development of Vasospastic Angina, but Not with Cardiovascular Outcomes
    Kim, Hyun-Jin
    Jo, Sang-Ho
    Lee, Min-Ho
    Seo, Won-Woo
    Baek, Sang Hong
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
  • [40] Influence of gender on the clinical characteristics and prognostic factors in patients with vasospastic angina
    Lee, Da Hyon
    Yang, Jeong Hoon
    Hahn, Joo Yong
    Jorge, Claudia
    Lee, Sang Hoon
    Pinto, Fausto J.
    Choi, Seung-Hyuk
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B200 - B200